DRUG · Unmapped registry intervention
Durysta, Bimatoprost Intracameral Implant 10 µg
Find medicine records ·
Find other trials using this name
Clinical trial
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
NCT07217678
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedBiomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Glaucomaverified · MONDO: glaucoma
Glaucoma Suspectunresolved
Interventions
Sponsors & collaborators
University of Miamilead sponsor
AbbViecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07217678 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.